Your browser doesn't support javascript.
loading
A Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of Pictilisib in Combination with Erlotinib in Patients with Advanced Solid Tumors.
Leong, Stephen; Moss, Rebecca A; Bowles, Daniel W; Ware, Joseph A; Zhou, Jing; Spoerke, Jill M; Lackner, Mark R; Shankar, Geetha; Schutzman, Jennifer L; van der Noll, Ruud; Voest, Emile E; Schellens, Jan H M.
Afiliação
  • Leong S; Division of Medical Oncology, University of Colorado Cancer Center, Aurora, Colorado, USA stephen.leong@ucdenver.edu.
  • Moss RA; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
  • Bowles DW; Division of Medical Oncology, University of Colorado Cancer Center, Aurora, Colorado, USA.
  • Ware JA; Genentech, Inc., South San Francisco, California, USA.
  • Zhou J; Genentech, Inc., South San Francisco, California, USA.
  • Spoerke JM; Genentech, Inc., South San Francisco, California, USA.
  • Lackner MR; Genentech, Inc., South San Francisco, California, USA.
  • Shankar G; Genentech, Inc., South San Francisco, California, USA.
  • Schutzman JL; Genentech, Inc., South San Francisco, California, USA.
  • van der Noll R; Division of Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Voest EE; Division of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Schellens JHM; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
Oncologist ; 22(12): 1491-1499, 2017 12.
Article em En | MEDLINE | ID: mdl-28798270
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sulfonamidas / Inibidores de Proteínas Quinases / Receptores ErbB / Cloridrato de Erlotinib / Indazóis / Neoplasias Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sulfonamidas / Inibidores de Proteínas Quinases / Receptores ErbB / Cloridrato de Erlotinib / Indazóis / Neoplasias Idioma: En Ano de publicação: 2017 Tipo de documento: Article